EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Background: Epidermal growth factor receptor (EGFR) mutation testing is recommended in metastatic non-small cell lung cancer (NSCLC). The objective of this study was to assess changes in EGFR mutation testing patterns and tyrosine kinase inhibitor (TKI) use in US veterans with stage III-IV NSCLC bet...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Anna Hung, Kyung Min Lee, Patrick R. Alba, Yanhong Li, Anthony Z. Gao, Bradley J. Hintze, Olga V. Efimova, Rahul Shenolikar, Melissa Pavilack, Dan Simmons, Michael J. Kelley, Julie A. Lynch, Shelby D. Reed
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2021-01-01
Serie:	Cancer Treatment and Research Communications
Soggetti:	Cancer genomics Targeted drug therapy
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2468294221000265
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!